Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.
Title | Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Pectasides, E., Chatzidakis I., Kotoula V., Koliou G-A., Papadopoulou K., Giannoulatou E., Giannouzakos V. G., Bobos M., Papavasileiou C., Chrisafi S., Florou A., Pectasides D., & Fountzilas G. |
Journal | Cancer Genomics Proteomics |
Volume | 17 |
Issue | 3 |
Pagination | 277-290 |
Date Published | 2020 May-Jun |
ISSN | 1790-6245 |
Abstract | BACKGROUND/AIM: Early-stage gastric cancer has a high risk of recurrence, despite trimodality therapy with surgery, chemotherapy and radiation. To improve patient selection for adjuvant chemoradiotherapy, we evaluated the prognostic significance of immunohistochemical and genetic biomarkers in patients with resected gastric adenocarcinoma. |
DOI | 10.21873/cgp.20188 |
Alternate Journal | Cancer Genomics Proteomics |
PubMed ID | 32345669 |